Hybrid lipid/clay carrier system containing Bixa orellana L.a tool for drug delivery
- Barbosa R 3
- Fátima García Villén 2
- Fernanda Nervo Raffin 3
- César Viseras Iborra 12
- Moura T 3
- 1 Andalusian Institute of Earth Sciences, CSIC-University of Granada, Granada, Spain.
- 2 Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Granada, Spain
- 3 Laboratory of Drug Development, Department of Pharmacy, Federal University of Rio Grande do Norte, Natal-RN, Brazi
ISSN: 2660-6356
Año de publicación: 2021
Título del ejemplar: XV CONGRESO DE LA SOCIEDAD ESPAÑOLA DE FARMACIA INDUSTRIA Y GALÉNICA
Volumen: 2
Número: 2
Páginas: 268-269
Tipo: Artículo
Otras publicaciones en: RESCIFAR Revista Española de Ciencias Farmacéuticas
Resumen
Nanocomposite systems attract considerable interest in the pharmaceutic and cosmetic fields due to the wide range of advantageous properties compared to free polymers, such as the high potential to provide predictable, accurate, and reproducible patterns of controlled release and specific delivery of bioactive molecules. Studies have shown the hybridization of different clays with polymers or surfactants by strong secondary interactions of the mineral compounds with their guests. Nanostructured lipid carriers (NLC) associated with clays have gained attention in pharmaceutical areas due to their ability to transport hydrophobic drugs. Additionally, lipid-based nanoparticles are considering “nano-safety, stable, biocompatible, and have low dermal toxicity. In this context, Bixa orellana L. or “annatto,” has been proposed as a potential active ingredient in pharmaceuticals by its biological activity as healing, antioxidant, antibacterial, and anti-leishmaniasis properties. The purpose of the present study was to produce and characterize NLCs with AO in association with Laponite (L) nanoparticles (Na+ 0.7[(Si8 Mg5.5Li0.3) O20(OH)4 ]-0.7).